1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk of rash with nilotinib: A systematic review of the literature and meta-analysis
    Meeting Abstract

    Drucker, A. M.; Wu, S.; Berman, E.; Lacouture, M. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • CA184-043: A randomized, double-blind, phase III trial comparing ipilimumab versus placebo following a single dose of radiotherapy (RT) in patients (pts) with castration-resistant prostate cancer (CRPC) who have received prior treatment with docetaxel (D)
    Meeting Abstract

    Drake, C. G.; Scher, H. I.; Bossi, A.; van den Eertwegh, A. J. M.; McHenry, B.; Fitzmaurice, T. F.; Cuillerot, J. M.; Chin, K. M.; Gagnier, P.; Fizazi, K.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Meeting Abstract

    Dueck, A. C.; Mendoza, T. R.; Mitchell, S. A.; Reeve, B. B.; Castro, K. M.; Denicoff, A.; O'Mara, A. M.; Rogak, L. J.; Clauser, S. B.; Bryant, D. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children's Oncology Group
    Meeting Abstract

    DuBois, S. G.; Krailo, M. D.; Gebhardt, M. C.; Donaldson, S. S.; Marcus, K. C.; Dormans, J. P.; Shamberger, R. C.; Sailer, S. L.; Nicholas, R. W.; Healey, J. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Bevacizumab for recurrent WHO grade III anaplastic glioma (AG)
    Meeting Abstract

    Delios, A. M.; Brennan, C. W.; Huse, J. T.; Colevas, K.; Omuro, A. M. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human phase I study of MORAb-004 (M4), a humanized monoclonal antibody recognizing endosialin (TEM-1), in patients with solid tumors
    Meeting Abstract

    Diaz, L. A.; Azad, N. S.; Gounder, M. M.; Coughlin, C. M.; Fishel, J.; O'Shannessy, D.; Grasso, L.; Wustner, J.; Aluri, J.; Parno, J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Advanced soft-tissue sarcoma in patients over age 75: Patterns of care and survival
    Meeting Abstract

    Decoopman, D. G.; Keohan, M. L.; Cioffi, A.; Maki, R. G.; Nguyen, B. B.; Italiano, A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Muller, S.; Fleisher, M.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer
    Meeting Abstract

    Dang, C. T.; Gianni, L.; Romieu, G.; Dirix, L.; Campone, M.; Citron, M. L.; Zamagni, C.; Krop, I. E.; Xu, N.; Smitt, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save